News About: Pharm. Industry
Drug makers achieve record sales in August
Pharmaceutical companies recorded the highest monthly sales of prescription drugs in August, according to market analysts.
Pharmaceutical manufacturers raked in 776.2 billion won in sales in August this year, up 18...
Novartis Korea Venture Fund invest $6 million to local biotech company
PharmAbcine, a specialized biotech company focused on the development of fully-human monoclonal antibodies for the treatment of cancer and inflammatory diseases, said on September 16 that it has received $6 million in...
Boehringer Ingelheim Korea release latest laxative
Boehringe Ingelheim Korea release latest laxative
Boehringer Ingelheim Korea released its latest Dulcolax Balance that is designed to recover the bowel movements in people with constipation.
Constipation is a ve...
Pharmacists start negotiation over 2010 health service fee
The Korean Pharmaceutical Association (KPA) started its annual health service fee negotiation with the National Health Insurance Corporation on September 17.
Earlier, the KPA officials said the association will exe...
Government to get more tough against rebate
The government will step up its fight against chronic illegal rebate practices whereby drug makers who are found to offer undue rebate to doctors or pharmacists in return for prescribing or recommending their products...
Japan to lure drug makers to home market
The Japanese government is considering offering more incentives to leading pharmaceutical companies into the domestic market as the country is experiencing a “new drug lag” over the United States, said an Japanese off...
HIRA to expand ‘data mining’ applications in drug logistics sector
The Health Insurance Review and Assessment Service (HIRA) is exploring a number of ‘data mining’ applications that can be used in domestic drug logistics business in an effort to make drug distribution channels more ...
Drug price-cut policy angers drug makers
Local and foreign drug manufacturers are opposing the Korean government’s plan to readjust the price of insurance-covered medicines.
Their reaction came out after the Ministry of Health and Welfare announced the pl...
Swine flu boosts shares of drug makers, sensitize/maks firms
Influenza A fears appear to have benefited some corporations in the medical and healthcare industries.
Swine flu is a boon to drug makers, sanitizer manufacturers and mask firms. Their shares skyrocketed recently, ...
Illegal rebate practice does not exist in Japan
The irregular business practices in Japan are no longer found in Japan due to tough law enforcement and voluntary reform in the pharmaceutical and wholesaling industry, according to Betsho Yoshiki, chairman of the Fed...
